Serum testosterone in women as measured by an automated immunoassay and a RIA.

References 1. Nicolaes GAF, Dahlback B. Factor V and thrombotic disease. Description of a Janus-faced protein. Arterioscler Thromb 2002;22:530–8. 2. Varadi K, Rosing J, Tans G, Pabinger I, Keil B, Schwarz HP. Factor V enhances the cofactor function of protein S in the APC mediated inactivation of factor VIII: influence of factor V R506Q mutation. Thromb Haemost 1996;76: 208–14. 3. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64–7. 4. Irani-Hakime N, Tamim H, Elias G, Finan RR, Daccache JL, Almawi WY. High prevalence of factor V mutation (Leiden) in the eastern Mediterranean. Clin Chem 2000;46:134–6. 5. Zivelin A, Griffin JH, Xu X, Pabinger I, Samama M, Conrad J, et al. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 1997;89:397–402. 6. Bernarde F, Faioni EM, Castoldi E, Lunghi B, Castaman G, Sacchi E, et al. A factor V genetic components differing from factor V R506Q contributes to the activated protein C resistance phenotype. Blood 1997;90:1552–7. 7. Awidi A, Shannak M, Bseiso A, Kailani MA, Omar N, Anshasi B, et al. High prevalence of factor V Leiden in healthy Jordanian Arabs. Thromb Haemost 1999;81:582–4. 8. Ozbek U, Tangun Y. Frequency of factor V Leiden (Arg506Gln) in Turkey. Br J Haematol 1997;97:504–5. 9. Zeinali S, Duca F, Zarbakhsh B, Tagliabue L, Mannucci PM. Thrombophilic mutations in Iran [Letter]. Thromb Haemost 2000;83:351–2. 10. Dzimiri N, Meyer B. World distribution of factor V Leiden [Letter]. Lancet 1996;347:481–2.